ClinicalTrials.govpublic full text
A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma
large b-cell lymphoma, glofitamab, polatuzumab vedotin, obinutuzumab, bridging therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 828554
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.